Bit Capital Gmb H Agenus Inc Transaction History

Bit Capital Gmb H

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Feb 12, 2025	SELL	$0.45 - $17.57 $1.39 Million - $54.3 Million	-3,088,722 Closed	0 $0
Q3 2023 Feb 12, 2025	BUY	$1.12 - $1.88 $81,427 - $136,681	72,703 Added 2.41%	3,088,722 $3.49 Billion
Q2 2023 Feb 12, 2025	BUY	$1.31 - $2.04 $2.69 Million - $4.19 Million	2,052,693 Added 213.08%	3,016,019 $4.83 Billion
Q1 2023 Feb 12, 2025	BUY	$1.45 - $2.95 $1.07 Million - $2.18 Million	739,858 Added 331.08%	963,326 $1.46 Billion
Q4 2022 Feb 12, 2025	BUY	$2.02 - $3.25 $451,405 - $726,271	223,468 New	223,468 $536 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.